Scientists take step toward creating artificial life

CHICAGO: In a major step toward creating artificial life, US researchers have developed a living organism that incorporates both natural and artificial DNA and is capable of creating entirely new, synthetic proteins.

The work, published in the journal Nature, brings scientists closer to the development of designer proteins made to order in a laboratory.

Previous work by Floyd Romesberg, a chemical biologist at the Scripps Research Institute in La Jolla, California, showed that it was possible to expand the genetic alphabet of natural DNA beyond its current four letters: adenine (A), cytosine (C), guanine (G) and thymine (T). In 2014, Romesberg and colleagues created a strain of E. coli bacteria that contained two unnatural letters, X and Y.

In the latest work, Romesberg’s team has shown that this partially synthetic form of E. coli can take instructions from this hybrid genetic alphabet to make new proteins.

“This is the first time ever a cell has translated a protein using something other than G, C, A or T,” Romesberg said.

Although the actual changes to the organism were small, the feat is significant, he said in an interview.

Creating new forms of life, however, is not the main point.

Romesberg is interested in using this expanded genetic alphabet to create new types of proteins that can be used to treat disease.

In 2014, he formed a company called Synthorx Inc, which is working on developing new protein-based treatments.

“A lot of proteins that you want to use as drugs get cleared in the kidney very quickly,” Romesberg said.

The new system would allow scientists to attach fat molecules to drugs to keep them in the body longer.